Literature DB >> 19775752

Changes in the metabolic footprint of placental explant-conditioned culture medium identifies metabolic disturbances related to hypoxia and pre-eclampsia.

W B Dunn1, M Brown, S A Worton, I P Crocker, D Broadhurst, R Horgan, L C Kenny, P N Baker, D B Kell, A E P Heazell.   

Abstract

Pre-eclampsia (PE) is a multi-system disorder thought to be mediated by circulating factors released from damaged placental villous trophoblast. There is extensive evidence of changes in the villous tissue in PE, some of which may be replicated by culturing villous tissue in hypoxic conditions. Metabolic footprinting offers a hypothesis-generating strategy to investigate factors released from this tissue in vitro. This study investigated differences in the factors released from villous trophoblast from uncomplicated pregnancies (n=6) and those with PE (n=6). In both cases, explanted placental villous fragments were cultured for 96 h in 1% O(2) (hypoxia) or 6% O(2) (placental normoxia). Metabolites consumed from and released into serum-conditioned culture medium were analysed by Ultra Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS). The relative concentration of 154 features of the metabolic footprint were observed to change in culture medium from uncomplicated pregnancies cultured in normoxic and hypoxic conditions (p<0.00005). 21 and 80 features were also different in culture medium from PE versus uncomplicated pregnancies cultured in hypoxic and normoxic conditions, respectively (p<0.00005). When comparing all 4 groups, 47 metabolic features showed a similar relative concentration in PE-derived media cultured in normoxic conditions to conditioned media from normal villous tissue cultured in hypoxic conditions. These data suggest that hypoxia may have a role in the placental pathogenesis of PE. Three areas of metabolism were highlighted for systems biology investigation; glutamate and glutamine, tryptophan metabolism and leukotriene or prostaglandin metabolism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19775752     DOI: 10.1016/j.placenta.2009.08.008

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  20 in total

1.  Oxygen levels that optimize TSC culture are identified by maximizing growth rates and minimizing stress.

Authors:  S Zhou; Y Xie; E E Puscheck; D A Rappolee
Journal:  Placenta       Date:  2011-04-21       Impact factor: 3.481

2.  Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery.

Authors:  Roberto Romero; Shali Mazaki-Tovi; Edi Vaisbuch; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Ricardo Gomez; Jyh Kae Nien; Bo Hyun Yoon; Moshe Mazor; Jingqin Luo; David Banks; John Ryals; Chris Beecher
Journal:  J Matern Fetal Neonatal Med       Date:  2010-05-26

3.  NMR-based metabolomics of mammalian cell and tissue cultures.

Authors:  Nelly Aranibar; Michael Borys; Nancy A Mackin; Van Ly; Nicholas Abu-Absi; Susan Abu-Absi; Matthias Niemitz; Bernhard Schilling; Zheng Jian Li; Barry Brock; Reb J Russell; Adrienne Tymiak; Michael D Reily
Journal:  J Biomol NMR       Date:  2011-03-04       Impact factor: 2.835

4.  Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry.

Authors:  Warwick B Dunn; David Broadhurst; Paul Begley; Eva Zelena; Sue Francis-McIntyre; Nadine Anderson; Marie Brown; Joshau D Knowles; Antony Halsall; John N Haselden; Andrew W Nicholls; Ian D Wilson; Douglas B Kell; Royston Goodacre
Journal:  Nat Protoc       Date:  2011-06-30       Impact factor: 13.491

Review 5.  Metabolomics in the developmental origins of obesity and its cardiometabolic consequences.

Authors:  M F Hivert; W Perng; S M Watkins; C S Newgard; L C Kenny; B S Kristal; M E Patti; E Isganaitis; D L DeMeo; E Oken; M W Gillman
Journal:  J Dev Orig Health Dis       Date:  2015-01-29       Impact factor: 2.401

6.  Women with preterm birth have a distinct cervicovaginal metabolome.

Authors:  Jeny Ghartey; Jamie A Bastek; Amy G Brown; Laura Anglim; Michal A Elovitz
Journal:  Am J Obstet Gynecol       Date:  2015-03-28       Impact factor: 8.661

7.  A review of omics approaches to study preeclampsia.

Authors:  Paula A Benny; Fadhl M Alakwaa; Ryan J Schlueter; Cameron B Lassiter; Lana X Garmire
Journal:  Placenta       Date:  2020-01-22       Impact factor: 3.481

Review 8.  Characterizing the lipid and metabolite changes associated with placental function and pregnancy complications using ion mobility spectrometry-mass spectrometry and mass spectrometry imaging.

Authors:  Kristin E Burnum-Johnson; Erin S Baker; Thomas O Metz
Journal:  Placenta       Date:  2017-03-29       Impact factor: 3.481

9.  Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification.

Authors:  Chen Liu; Wei Wang; Nicholas Parchim; Roxanna A Irani; Sean C Blackwell; Baha Sibai; Jianping Jin; Rodney E Kellems; Yang Xia
Journal:  Hypertension       Date:  2013-11-04       Impact factor: 10.190

Review 10.  Metabolomics: a valuable tool for stem cell monitoring in regenerative medicine.

Authors:  Laura E McNamara; Terje Sjöström; R M Dominic Meek; Richard O C Oreffo; Bo Su; Matthew J Dalby; Karl E V Burgess
Journal:  J R Soc Interface       Date:  2012-05-23       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.